Details for New Drug Application (NDA): 020471
✉ Email this page to a colleague
The generic ingredient in ZYFLO is zileuton. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the zileuton profile page.
Pharmacology for NDA: 020471
Mechanism of Action | 5-Lipoxygenase Inhibitors |
Physiological Effect | Decreased Leukotriene Production |
Suppliers and Packaging for NDA: 020471
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ZYFLO | zileuton | TABLET;ORAL | 020471 | NDA | Chiesi USA, Inc. | 10122-901 | 10122-901-12 | 120 TABLET in 1 BOTTLE (10122-901-12) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 300MG | ||||
Approval Date: | Dec 9, 1996 | TE: | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 600MG | ||||
Approval Date: | Dec 9, 1996 | TE: | RLD: | Yes |
Expired US Patents for NDA 020471
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Chiesi | ZYFLO | zileuton | TABLET;ORAL | 020471-001 | Dec 9, 1996 | ⤷ Sign Up | ⤷ Sign Up |
Chiesi | ZYFLO | zileuton | TABLET;ORAL | 020471-003 | Dec 9, 1996 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription